Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters

Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters

Background: Unfractionated heparin (UFH) is used as an anticoagulant during the atrial fibrillation (AF) ablation procedure to prevent the occurrence of thromboembolic events. Guidelines recommend an activated clotting time (ACT) greater than 300 s (s) based on studies of patients treated with vitam...

Full description

Bibliographic Details
Main Authors: Marie Muller, Julien Godet, Xavier Delabranche, Laurent Sattler, David Millard, Halim Marzak, Paul Michel Mertes, Annick Steib, Lelia Grunebaum, Laurence Jesel, Charles Ambroise Tacquard
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Clinical Medicine
Subjects:
atrial fibrillation ablation
heparin
ACT
direct oral anticoagulant
anti-Xa
Online Access:https://www.mdpi.com/2077-0383/12/6/2236

Internet

https://www.mdpi.com/2077-0383/12/6/2236

Similar Items